RESUMEN
AIM: Using proteomics, we aimed to identify the proteins differentially regulated by dexamethasone in the mouse cochlea based on mass-spectrometry data. BACKGROUND: Glucocorticoid therapy is widely used for many forms of sensorineural hearing loss; however, the molecular mechanism of its action in the cochlea remains poorly understood. METHODS: Dexamethasone or control saline was intratympanically applied to the cochleae of mice. Twelve hours after application, proteins differentially regulated by dexamethasone in the cochlea were analyzed by isobaric Tag for Relative and Absolute Quantitation (iTRAQ)-mass spectrometry. Next, dexamethasone-dependent regulation of these proteins was verified in the cochleae of mice with noise-induced hearing loss (NIHL) and systemic administration of dexamethasone by western blotting. Immunolocalizations of these proteins were examined in cochleae with NIHL. RESULTS: A total of 247 proteins with a greater than 95% confidence interval of protein identification were found, and 11 differentially expressed proteins by dexamethasone were identified by the iTRAQ-mass spectrometry. One protein, myelin protein zero (Mpz), was upregulated (1.870 ± 0.201-fold change, p < 0.01) at 6 hours post-systemic dexamethasone and noise exposure in a mouse model of NIHL. Heat shock protein 70 (Hsp70) was downregulated (0.511 ± 0.274-fold change, p < 0.05) at 12 hours post-systemic dexamethasone. Immunohistochemistry confirmed Mpz localization to the efferent and afferent processes of the spiral neurons, whereas Hsp70 showed a more ubiquitous expression pattern in the cochlea. CONCLUSION: Both Mpz and Hsp70 have been reported to be closely associated with sensorineural hearing loss in humans. Dexamethasone significantly modulated the expression levels of these proteins in the cochleae of mice.
Asunto(s)
Antiinflamatorios/farmacología , Cóclea/metabolismo , Sordera/genética , Dexametasona/farmacología , Proteínas HSP70 de Choque Térmico/biosíntesis , Proteínas HSP70 de Choque Térmico/genética , Proteína P0 de la Mielina/biosíntesis , Proteína P0 de la Mielina/genética , Proteómica/métodos , Administración Tópica , Animales , Antiinflamatorios/administración & dosificación , Antiinflamatorios/uso terapéutico , Cóclea/efectos de los fármacos , Sordera/tratamiento farmacológico , Dexametasona/administración & dosificación , Dexametasona/uso terapéutico , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Pérdida Auditiva Provocada por Ruido/tratamiento farmacológico , Pérdida Auditiva Provocada por Ruido/genética , Pérdida Auditiva Provocada por Ruido/metabolismo , Pérdida Auditiva Sensorineural/tratamiento farmacológico , Pérdida Auditiva Sensorineural/genética , Inyecciones Intraperitoneales , Ratones , Ratones Endogámicos C57BL , Células Receptoras Sensoriales/efectos de los fármacos , Células Receptoras Sensoriales/metabolismo , Membrana TimpánicaRESUMEN
INTRODUCTION: We examined the effects of gastrocnemius eccentric contractions (ECs) on the sciatic nerve in rats. METHODS: Rats were divided randomly into the following 3 groups: control, 180EC (ECs with 180°/s angular velocity), and 30EC (ECs with 30°/s angular velocity). Twenty ECs were induced by electrical stimulation of the gastrocnemius. On days 3, 7, and 10 after the ECs, nerve conduction velocity (NCV) was measured, and sciatic nerve branches were harvested for analysis. RESULTS: A significant decrease in NCV was observed between the control and day-7 180EC. Significant reduction in the levels of myelin sheath protein zero (p0) between day 7 and day 3 180EC and a significant increase of macrophage-related protein and tyrosine kinase receptor C were observed between day 7 180EC and day 7 30EC. CONCLUSIONS: ECs with fast angular velocities induce functional and structural damage in innervating nerve.
Asunto(s)
Músculo Esquelético/lesiones , Músculo Esquelético/inervación , Nervio Ciático/lesiones , Animales , Western Blotting , Estimulación Eléctrica , Proteína GAP-43/biosíntesis , Proteína GAP-43/genética , Regulación de la Expresión Génica/fisiología , Inmunohistoquímica , Contracción Isométrica/fisiología , Macrófagos/metabolismo , Masculino , Contracción Muscular/fisiología , Proteínas Musculares/biosíntesis , Proteínas Musculares/genética , Proteína P0 de la Mielina/biosíntesis , Proteína P0 de la Mielina/genética , Conducción Nerviosa/fisiología , Ratas , Ratas Wistar , Receptor trkC/metabolismoRESUMEN
The rat dorsal root ganglia (DRG) model is a long-standing in vitro model for analysis of myelination in the peripheral nervous system. For performing systematic, high throughput analysis with transgenic animals, a simplified BL6 mouse protocol is indispensable. Here we present a stable and reliable protocol for myelinating co-cultures producing a high myelin ratio using cells from C57BL/6 mice. As an easy accessible and operable method, Sudan staining proved to be efficient in myelin detection for fixed cultures. Green fatty acid stain turned out to be highly reliable for analysis of the dynamic biological processes of myelination in vital cultures. Once myelinated we were able to induce demyelination by the addition of forskolin into the model system. In addition, we provide an optimised rat DRG protocol with significantly improved myelin ratio and a comparison of the protocols presented. Our results strengthen the value of ex vivo myelination models in neurobiology.
Asunto(s)
Vaina de Mielina/fisiología , Animales , Compuestos Azo , Western Blotting , Compuestos de Boro , Células Cultivadas/fisiología , Colforsina/farmacología , Colorantes , Enfermedades Desmielinizantes , Colorantes Fluorescentes , Ganglios Espinales/fisiología , Ratones , Ratones Endogámicos C57BL , Microscopía Electrónica , Microscopía Fluorescente , Proteína Básica de Mielina/biosíntesis , Proteína Básica de Mielina/genética , Proteína P0 de la Mielina/biosíntesis , Proteína P0 de la Mielina/genética , Vaina de Mielina/ultraestructura , Naftalenos , Ácidos Palmíticos , Cultivo Primario de Células , Ratas , Ratas Endogámicas Lew , Ratas Wistar , Reacción en Cadena en Tiempo Real de la Polimerasa , Células de Schwann/metabolismo , Nervio Ciático/citología , Especificidad de la Especie , Coloración y Etiquetado/métodosRESUMEN
BACKGROUND: Electrical stimulation (ES) has been shown to promote nerve regeneration when it was applied to the proximal nerve stump. However, the possible beneficial effect of establishing a local electrical environment between a large nerve defect on nerve regeneration has not been reported in previous studies. The present study attempted to establish a local electrical environment between a large nerve defect, and examined its effect on nerve regeneration and functional recovery. METHODOLOGY/FINDINGS: In the present study, a conductive scaffold was constructed and used to bridge a 15 mm sciatic nerve defect in rats, and intermittent ES (3 V, 20 Hz) was applied to the conductive scaffold to establish an electrical environment at the site of nerve defect. Nerve regeneration and functional recovery were examined after nerve injury repair and ES. We found that axonal regeneration and remyelination of the regenerated axons were significantly enhanced by ES which was applied to conductive scaffold. In addition, both motor and sensory functional recovery was significantly improved and muscle atrophy was partially reversed by ES localized at the conductive scaffold. Further investigations showed that the expression of S-100, BDNF (brain-derived neurotrophic factor), P0 and Par-3 was significantly up-regulated by ES at the conductive scaffold. CONCLUSIONS/SIGNIFICANCE: Establishing an electrical environment with ES localized at the conductive scaffold is capable of accelerating nerve regeneration and promoting functional recovery in a 15 mm nerve defect in rats. The findings provide new directions for exploring regenerative approaches to achieve better functional recovery in the treatment of large nerve defect.
Asunto(s)
Axones/fisiología , Estimulación Eléctrica , Vaina de Mielina/metabolismo , Regeneración Nerviosa/fisiología , Potenciales de Acción , Animales , Axones/patología , Factor Neurotrófico Derivado del Encéfalo/biosíntesis , Proteínas Portadoras/biosíntesis , Quitosano/química , Modelos Animales de Enfermedad , Electrofisiología/métodos , Masculino , Proteína P0 de la Mielina/biosíntesis , Proteínas del Tejido Nervioso , Neuronas/metabolismo , Ratas , Ratas Sprague-Dawley , Proteínas S100/biosíntesis , Nervio Ciático/patología , Regulación hacia ArribaRESUMEN
Myelin protein zero (P0 or MPZ) is a major myelin protein (â¼30 kDa) expressed in the peripheral nervous system (PNS) in terrestrial vertebrates. Several groups have detected a P0-related 36-kDa (or 35-kDa) protein that is expressed in the PNS as an antigen for the serum IgG of patients with neuropathy. The molecular structure and function of this 36-kDa protein are, however, still unknown. We hypothesized that the 36-kDa protein may be derived from P0 mRNA by stop codon readthrough. We found a highly conserved region after the regular stop codon in predicted sequences from the 3'-UTR of P0 in higher animals. MS of the 36-kDa protein revealed that both P0 peptides and peptides deduced from the P0 3'-UTR sequence were found among the tryptic fragments. In transfected cells and in an in vitro transcription/translation system, the 36-kDa molecule was also produced from the identical mRNA that produced P0. We designated this 36-kDa molecule as large myelin protein zero (L-MPZ), a novel isoform of P0 that contains an additional domain at the C terminus. In the PNS, L-MPZ was localized in compact myelin. In transfected cells, just like P0, L-MPZ was localized at cell-cell adhesion sites in the plasma membrane. These results suggest that L-MPZ produced by the stop codon readthrough mechanism is potentially involved in myelination. Since this is the first finding of stop codon readthrough in a common mammalian protein, detailed analysis of L-MPZ expression will help to understand the mechanism of stop codon readthrough in mammals.
Asunto(s)
Codón de Terminación/metabolismo , Regulación de la Expresión Génica/fisiología , Proteína P0 de la Mielina/biosíntesis , Animales , Enfermedad Crónica , Codón de Terminación/genética , Enfermedades Desmielinizantes/genética , Enfermedades Desmielinizantes/metabolismo , Femenino , Células HeLa , Humanos , Ratones , Persona de Mediana Edad , Proteína P0 de la Mielina/genética , Vaina de Mielina/genética , Vaina de Mielina/metabolismo , Células 3T3 NIH , Isoformas de Proteínas/biosíntesis , Isoformas de Proteínas/genética , Ratas , Ratas WistarRESUMEN
Previous studies have demonstrated that electrical stimulation (ES) enhances axonal regeneration following central and peripheral nerve injury. However, the effect of ES on peripheral remyelination after nerve damage has been investigated less, and the mechanism underlying its action remains unclear. In the present study, neuron/Schwann cell (SC) co-cultures in vitro and crush-injured sciatic nerves in rats were subjected to 1 h of continuous ES (20 Hz, 100 micros, 3 V). Electron microscopy and nerve morphometry were performed to investigate the extent of regenerated nerve myelination. The expression profiles of P0, Par-3 and brain-derived neurotrophic factor (BDNF) in vitro and in vivo were examined by western blotting. We reported that 20 Hz ES increased the number of regenerated and myelinated axons at 4 and 8 weeks after injury. P0 level in the ES-treated groups, as well as myelin sheath thickness, were enhanced compared with the controls. The earlier peak Par-3 in the ES-treated groups indicated earlier initiation of SC myelination. Moreover, the similar results were achieved in the cell co-culture. Additionally, brief ES significantly elevated BDNF expression in co-cultured cells and nerve tissues. In conclusion, ES of the site of nerve injury potentiates axonal regrowth and myelin maturation during peripheral nerve regeneration. Further, the therapeutic actions of ES on myelination that is mediated via enhanced BDNF signals, which driving the promyelination effect on SCs at the onset of myelination.
Asunto(s)
Terapia por Estimulación Eléctrica , Vaina de Mielina/patología , Factores de Crecimiento Nervioso/biosíntesis , Nervio Ciático/metabolismo , Animales , Axones/ultraestructura , Factor Neurotrófico Derivado del Encéfalo/biosíntesis , Proteínas Portadoras/biosíntesis , Células Cultivadas , Técnicas de Cocultivo , Proteína P0 de la Mielina/biosíntesis , Vaina de Mielina/metabolismo , Regeneración Nerviosa , Proteínas del Tejido Nervioso , Neuronas/metabolismo , Neuronas/patología , Ratas , Ratas Sprague-Dawley , Células de Schwann/metabolismo , Células de Schwann/patología , Nervio Ciático/lesiones , Nervio Ciático/patologíaRESUMEN
The interleukin-6 (IL-6) family of cytokines is thought to be involved in the development and regeneration of peripheral nerves; however, their roles in myelination remain unclear. In this study, we examined the effects of IL-6 on the expression of genes for compact myelin proteins using Schwann cell cultures prepared by multiple explantation of adult rat sciatic nerves. In semi-quantitative reverse transcription-polymerase chain reaction analysis, stimulation of Schwann cells with IL-6 significantly increased the mRNA level of peripheral myelin protein 22 (PMP22), but not those of myelin protein zero and myelin basic protein. The increase in PMP22 mRNA was markedly suppressed by AG490, a Janus kinase 2 (JAK2) inhibitor, but not significantly by PD098059, a mitogen-activated protein kinase inhibitor. Immunocytochemical staining revealed that IL-6 enhanced immunoreactivities for the phosphorylated forms of both JAK2 and signal transducer and activator of transcription 3 (STAT3), as well as that for PMP22. These results indicate that IL-6 can enhance PMP22 production in Schwann cells via a JAK2-dependent pathway by probably activating STAT3 and thus may contribute to myelination.
Asunto(s)
Interleucina-6/fisiología , Janus Quinasa 2/fisiología , Proteínas de la Mielina/biosíntesis , Células de Schwann/metabolismo , Animales , Células Cultivadas , Receptor gp130 de Citocinas/fisiología , Interleucina-6/farmacología , Janus Quinasa 2/antagonistas & inhibidores , Masculino , Quinasas de Proteína Quinasa Activadas por Mitógenos/antagonistas & inhibidores , Proteína Básica de Mielina/biosíntesis , Proteína Básica de Mielina/genética , Proteína P0 de la Mielina/biosíntesis , Proteína P0 de la Mielina/genética , Proteínas de la Mielina/genética , Fosforilación , ARN Mensajero/biosíntesis , Ratas , Ratas Wistar , Proteínas Recombinantes/farmacología , Factor de Transcripción STAT3/metabolismo , Nervio Ciático/citología , Nervio Ciático/metabolismo , Transducción de Señal , Regulación hacia ArribaRESUMEN
Pituitary gland is a well-known endocrine tissue. The hypothalamo-neurohypophysial system, containing arginine vasopressin and oxytocin, shows a reversible morphological reorganization of both neurons and glial cells during chronic physiological stimulations. Since many signal transducing and cell adhesion molecules (CAMs) are recovered in membrane microdomain (MD) fractions, MDs are considered as signaling platforms of cells. In order to know the molecular background for these endocrine systems, we characterized MD-components derived from rat pituitary and found specific enrichment of several proteins in the fraction. One of them was identified as myelin protein zero (P0) with mass analysis and this result was further confirmed by a result that a specific antibody to this protein reacted to the authentic P0 protein in the myelin fraction of rat sciatic nerve. P0 is one of type-I transmembrane CAMs and a major structural component of mammalian peripheral nerve myelin. In mammals, expression of P0 has been considered to be restricted to peripheral nervous system. This result however indicates that P0 expresses more widely and its enrichment in the MD-fraction from rat pituitary suggests the participation in cell-cell communications.
Asunto(s)
Microdominios de Membrana/metabolismo , Proteína P0 de la Mielina/biosíntesis , Hipófisis/metabolismo , Transducción de Señal/fisiología , Animales , Anticuerpos Monoclonales/química , Arginina Vasopresina/metabolismo , Inmunohistoquímica , Microdominios de Membrana/química , Microdominios de Membrana/inmunología , Proteína P0 de la Mielina/química , Proteína P0 de la Mielina/inmunología , Proteína P0 de la Mielina/aislamiento & purificación , Oxitocina/metabolismo , Hipófisis/química , Hipófisis/citología , Hipófisis/inmunología , Ratas , Ratas Wistar , Nervio Ciático/química , Nervio Ciático/citología , Nervio Ciático/inmunología , Nervio Ciático/metabolismoRESUMEN
Differential targeting of myelin proteins to multiple, biochemically and functionally distinct Schwann cell plasma membrane domains is essential for myelin formation. In this study, we investigated whether the myelin protein P0 contains targeting signals using Madin-Darby canine kidney (MDCK) cells. By confocal microscopy, P0 was localized to MDCK cell basolateral membranes. C-terminal deletion resulted in apical accumulation, and stepwise deletions defined a 15-mer region that was required for basolateral targeting. Alanine substitutions within this region identified the YAML sequence as a functional tyrosine-based targeting signal, with the ML sequence serving as a secondary leucine-based signal. Replacement of the P0 ectodomain with green fluorescent protein altered the distribution of constructs lacking the YAML signal. Coexpression of the myelin-associated glycoprotein did not alter P0 distribution in MDCK cells. The results indicate that P0 contains a hierarchy of targeting signals, which may contribute to P0 localization in myelinating Schwann cells and the pathogenesis in human disease.
Asunto(s)
Marcación de Gen/métodos , Leucina , Proteína P0 de la Mielina/metabolismo , Tirosina , Secuencias de Aminoácidos/genética , Secuencia de Aminoácidos , Animales , Línea Celular , Perros , Leucina/genética , Datos de Secuencia Molecular , Proteína P0 de la Mielina/biosíntesis , Proteína P0 de la Mielina/genética , Ratas , Transducción de Señal/genética , Transfección , Tirosina/genéticaRESUMEN
To investigate the role of erbB signaling in the interactions between peripheral axons and myelinating Schwann cells, we generated transgenic mice expressing a dominant-negative erbB receptor in these glial cells. Mutant mice have delayed onset of myelination, thinner myelin, shorter internodal length, and smaller axonal caliber in adulthood. Consistent with the morphological defects, transgenic mice also have slower nerve conduction velocity and defects in their responses to mechanical stimulation. Molecular analysis indicates that erbB signaling may contribute to myelin formation by regulating transcription of myelin genes. Analysis of sciatic nerves showed a reduction in the levels of expression of myelin genes in mutant mice. In vitro assays revealed that neuregulin-1 (NRG1) induces expression of myelin protein zero (P0). Furthermore, we found that the effects of NRG1 on P0 expression depend on the NRG1 isoform used. When NRG1 is presented to Schwann cells in the context of cell-cell contact, type III but not type I NRG1 regulates P0 gene expression. These results suggest that disruption of the NRG1-erbB signaling pathway could contribute to the pathogenesis of peripheral neuropathies with hypomyelination and neuropathic pain.
Asunto(s)
Fibras Nerviosas Mielínicas/metabolismo , Neurregulina-1/metabolismo , Proteínas Oncogénicas v-erbB/genética , Nervios Periféricos/crecimiento & desarrollo , Células de Schwann/metabolismo , Sensación/genética , Animales , Axones/metabolismo , Axones/patología , Comunicación Celular/genética , Diferenciación Celular/genética , Modelos Animales de Enfermedad , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Regulación del Desarrollo de la Expresión Génica/fisiología , Ratones , Ratones Transgénicos , Proteína P0 de la Mielina/biosíntesis , Proteína P0 de la Mielina/genética , Proteínas de la Mielina/biosíntesis , Proteínas de la Mielina/genética , Vaina de Mielina/genética , Vaina de Mielina/metabolismo , Fibras Nerviosas Mielínicas/patología , Conducción Nerviosa/genética , Neurregulina-1/genética , Neurregulina-1/farmacología , Nervios Periféricos/metabolismo , Nervios Periféricos/patología , Enfermedades del Sistema Nervioso Periférico/genética , Enfermedades del Sistema Nervioso Periférico/metabolismo , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Isoformas de Proteínas/farmacología , Células de Schwann/patología , Nervio Ciático/crecimiento & desarrollo , Nervio Ciático/metabolismo , Nervio Ciático/patologíaRESUMEN
Mutations in the gene encoding for myelin protein zero (MPZ) cause inherited demyelinating peripheral neuropathies of different severity. The molecular and cellular mechanisms by which the MPZ mutations cause neuropathy are incompletely understood. We investigated MPZ, myelin basic protein, and peripheral myelin protein 22 (PMP22) protein expression levels in a nerve biopsy of a Charcot-Marie-Tooth type 1B patient heterozygous for the Val 102 frame-shift mutation. We demonstrate by quantitative immunohistochemical as well as by Western blot analyses that MPZ expression levels were not reduced in myelin membranes, a finding that is in accordance with the mild phenotype of this patient. Our data show that heterozygous 'loss-of-function' of MPZ may not necessarily lead to reduced protein levels. In conclusion, we demonstrate that careful analysis of protein expression levels in peripheral nerve tissues provides important information with respect to the understanding of the molecular basis of these neuropathies.
Asunto(s)
Enfermedades Desmielinizantes/genética , Enfermedades Desmielinizantes/metabolismo , Proteína P0 de la Mielina/biosíntesis , Proteína P0 de la Mielina/genética , Nervio Sural/metabolismo , Adulto , Biopsia , Western Blotting , Enfermedades Desmielinizantes/patología , Femenino , Mutación del Sistema de Lectura , Humanos , Inmunohistoquímica , Proteínas de la Mielina/biosíntesis , Linaje , Fenotipo , Nervio Sural/química , Nervio Sural/patologíaRESUMEN
Schwann cells are the myelinating glia of the peripheral nervous system, and their development is regulated by various growth factors, such as neuregulin, platelet-derived growth factor (PDGF), and insulin-like growth factor-I (IGF-I). However, the mechanism of intracellular signaling pathways following these ligand stimuli in Schwann cell differentiation remains elusive. Here, we demonstrate that in cultured Schwann cells, neuregulin and PDGF suppressed the expression of myelin-associated protein markers, whereas IGF-I promoted it. Although these ligands activated common downstream signaling pathways [i.e., extracellular signal-regulated kinase (Erk) and phosphatidylinositol-3-kinase (PI3K)-Akt pathways], the profiles of activation varied among ligands. To elucidate the function of these pathways and the mechanisms underlying Schwann cell differentiation, we used adenoviral vectors to selectively activate or inactivate these pathways. We found that the selective activation of Erk pathways suppressed Schwann cell differentiation, whereas that of PI3K pathways promoted it. Furthermore, lithium chloride, a modulator of glycogen synthase kinase-3beta (GSK-3beta) promoted Schwann cell differentiation, suggesting the involvement of GSK-3beta as a downstream molecule of PI3K-Akt pathways. Selective activation of PI3K pathways in Schwann cells by gene transfer also demonstrated increased myelination in in vitro Schwann cell-DRG neuron cocultures and in vivo allogenic nerve graft experiments. We conclude that signals mediated by PI3K-Akt are crucial for initiation of myelination and that the effects of growth factors are primarily dependent on the balance between Erk and PI3K-Akt activation. Our results also propose the possibility of augmenting Schwann cell functions by modulating intracellular signals in light of future cell therapies.
Asunto(s)
Quinasas MAP Reguladas por Señal Extracelular/fisiología , Vaina de Mielina/fisiología , Fosfatidilinositol 3-Quinasas/fisiología , Proteínas Serina-Treonina Quinasas/fisiología , Proteínas Proto-Oncogénicas/fisiología , Células de Schwann/enzimología , Nervio Ciático/trasplante , Transducción de Señal/fisiología , Animales , Diferenciación Celular/efectos de los fármacos , Células Cultivadas/efectos de los fármacos , Células Cultivadas/enzimología , Células Cultivadas/fisiología , Técnicas de Cocultivo , Colforsina/farmacología , Activación Enzimática/efectos de los fármacos , Quinasas MAP Reguladas por Señal Extracelular/genética , Ganglios Espinales/citología , Regulación de la Expresión Génica/efectos de los fármacos , Glucógeno Sintasa Quinasa 3/efectos de los fármacos , Glucógeno Sintasa Quinasa 3/fisiología , Glucógeno Sintasa Quinasa 3 beta , Factor I del Crecimiento Similar a la Insulina/farmacología , Cloruro de Litio/farmacología , MAP Quinasa Quinasa 1/genética , MAP Quinasa Quinasa 1/fisiología , Proteína Básica de Mielina/biosíntesis , Proteína Básica de Mielina/genética , Proteína P0 de la Mielina/biosíntesis , Proteína P0 de la Mielina/genética , Glicoproteína Asociada a Mielina/biosíntesis , Glicoproteína Asociada a Mielina/genética , Neurregulina-1/farmacología , Neuronas Aferentes/citología , Fosfatidilinositol 3-Quinasas/genética , Fosforilación , Factor de Crecimiento Derivado de Plaquetas/farmacología , Procesamiento Proteico-Postraduccional , Proteínas Serina-Treonina Quinasas/genética , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas c-akt , Ratas , Ratas Wistar , Proteínas Recombinantes de Fusión/fisiología , Células de Schwann/efectos de los fármacos , Células de Schwann/fisiología , Nervio Ciático/citología , Transducción de Señal/efectos de los fármacos , Trasplante Homólogo , Proteínas ras/fisiologíaRESUMEN
Axonal degeneration is the major cause of permanent neurological disability in individuals with inherited diseases of myelin. Axonal and neuronal changes that precede axonal degeneration, however, are not well characterized. We show here that dysmyelinated lower motor neurons retract and regenerate dysfunctional presynaptic terminals, leading to severe neurological disability before axonal degeneration. In addition, dysmyelination led to a decreased synaptic quantal content, an indicator of synaptic dysfunction. The amplitude and rise time of miniature endplate potentials were also increased, but these changes were primarily consistent with an increase in the passive membrane properties of the transgenic muscle fibers. Maintenance of synaptic connections should be considered as a therapeutic target for slowing progression of neurological disability in primary diseases of myelin.
Asunto(s)
Enfermedades Desmielinizantes/fisiopatología , Neuropatía Hereditaria Motora y Sensorial/fisiopatología , Neuronas Motoras/fisiología , Regeneración Nerviosa , Unión Neuromuscular/fisiopatología , Terminales Presinápticos/fisiología , Animales , Enfermedades Desmielinizantes/genética , Enfermedades Desmielinizantes/patología , Evaluación de la Discapacidad , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Electromiografía , Neuropatía Hereditaria Motora y Sensorial/genética , Neuropatía Hereditaria Motora y Sensorial/patología , Ratones , Ratones Transgénicos , Neuronas Motoras/patología , Músculo Esquelético/inervación , Músculo Esquelético/fisiopatología , Atrofia Muscular/patología , Proteína P0 de la Mielina/biosíntesis , Proteína P0 de la Mielina/genética , Regeneración Nerviosa/genética , Unión Neuromuscular/patología , Terminales Presinápticos/patología , Células de Schwann/metabolismo , Células de Schwann/patología , Transmisión Sináptica , Vesículas Sinápticas/metabolismo , Vesículas Sinápticas/patologíaRESUMEN
Genetic deficiency or instability of myelin protein zero (P0) results in hereditary motor sensory neuropathy. In view of recent advances in gene therapy, substitution of the molecular defect may become realistic in the near future. Here we investigate the impact of genetic deficiency of P0 on selection of the autoreactive T cell repertoire in the corresponding mouse model. We show that P0 mRNA transcripts are expressed in thymic stroma, similar to other myelin proteins and that expression of intact P0 protein can be detected by Western blot. Using a library of overlapping 20mer peptides spanning the entire length of P0 and applying the ELISPOT technique, we detected a strong immune response toward P0 extracellular domain peptide aa 41-60 in P0(-/-) knockout mice, but not in heterozygous P0(+/-) or wild-type (wt) mice. In addition, one cryptic epitope and two subdominant epitopes of P0 were identified. Using P0(-/-) into wt bone marrow (BM) chimeras we found that P0 expression in the host suffices for full tolerance induction, which is in line with its presence in thymic stroma. However, repopulation of P0(-/-) mice with wt BM led to partial induction of tolerance, suggesting that BM derived cells can also express this protein. Our findings may have implications for secondary autoimmunity developing after gene therapy in hereditary neuropathies and other diseases with genetically determined protein deficiency, because the repaired protein will then represent a foreign, nontolerized Ag.
Asunto(s)
Tolerancia Inmunológica , Proteína P0 de la Mielina/biosíntesis , Timo/inmunología , Timo/metabolismo , Secuencia de Aminoácidos , Animales , Presentación de Antígeno/genética , Células de la Médula Ósea/inmunología , Células de la Médula Ósea/metabolismo , Células de la Médula Ósea/efectos de la radiación , Diferenciación Celular/genética , Diferenciación Celular/inmunología , Epítopos de Linfocito T/administración & dosificación , Epítopos de Linfocito T/análisis , Epítopos de Linfocito T/metabolismo , Feto , Dosificación de Gen , Células Madre Hematopoyéticas/inmunología , Células Madre Hematopoyéticas/metabolismo , Células Madre Hematopoyéticas/efectos de la radiación , Tolerancia Inmunológica/genética , Epítopos Inmunodominantes/administración & dosificación , Epítopos Inmunodominantes/análisis , Epítopos Inmunodominantes/metabolismo , Memoria Inmunológica/genética , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Datos de Secuencia Molecular , Proteína P0 de la Mielina/deficiencia , Proteína P0 de la Mielina/inmunología , Proteína P0 de la Mielina/metabolismo , Técnicas de Cultivo de Órganos , Fragmentos de Péptidos/administración & dosificación , Fragmentos de Péptidos/inmunología , Fragmentos de Péptidos/metabolismo , Quimera por Radiación/inmunología , Subgrupos de Linfocitos T/citología , Subgrupos de Linfocitos T/inmunología , Subgrupos de Linfocitos T/metabolismo , Timo/citologíaRESUMEN
Leg lengthening with nerve elongation is a common clinical treatment. We investigated morphological and molecular changes in peripheral nerves associated with femoral lengthening using animal models. Sciatic nerves of 13 week old male Wistar rats (n = 35) were elongated indirectly by leg lengthening for 14 days at 1 mm/day. At 3, 7, 14, 21, and 35 days following initiation of elongation, sciatic nerves on the elongated side and contralateral (control) side were excised at the midpoint of the femur. Internodal length was increased by 17%. Light and electron microscopic observation of transverse sections at 14 days showed elongated nerves appearing similar to control nerves with no degenerating axons and normal myelin thickness. We next examined changes of mRNA expression of a major myelin glycoprotein, P0, in elongated nerves using a quantitative reverse transcription-polymerase chain reaction and in situ hybridization. P0 mRNA expression in elongated nerves was increased during the first 3 weeks, with expression reaching 160% of control nerve expression at 14 days. Results of in situ hybridization were confirmatory. We concluded that myelin synthesis occurred during gradual nerve elongation. In adulthood, Schwann cells retain ability to synthesize myelin in response to nerve stretching.
Asunto(s)
Alargamiento Óseo , Proteína P0 de la Mielina/biosíntesis , Nervios Periféricos/fisiología , ARN Mensajero/biosíntesis , Animales , Hibridación in Situ , Masculino , Vaina de Mielina/metabolismo , Estimulación Física , Ratas , Ratas Wistar , Reacción en Cadena de la Polimerasa de Transcriptasa InversaRESUMEN
The observations here reported indicate that, in vivo, the expression of an important protein of peripheral myelin, the glycoprotein Po, is influenced by mifespristone (RU 38486), that is, an antagonist of progesterone (PR) and glucocorticoid (GR) receptor. In our experimental model, male rats have been treated at the first day of life with this antagonist and after repeated treatments, we have analyzed in the sciatic nerve of 20- (20d) and 30-day-old rats (30d) the mRNA and protein levels of Po. Moreover, expression of Po has also been analyzed in the sciatic nerve of animals treated during the first 30 days of postnatal life and then sacrificed at 90th day of life (90d). The results obtained have indicated that both mRNA and protein levels of Po decrease at 20d. Apparently, these effects seem to be transient because no changes are evident at the other two times of analysis. As shown by morphometric analysis, the treatment with RU 38486 is also able to induce morphological changes at the level of sciatic nerve. However, at variance to what is expected by an alteration of an important component of the myelin membranes like Po, no changes are evident at the level of the myelin compartment. On the contrary, a significant reduction of axon diameter in parallel to an increase in neurofilament (NF) density occurs since 30d. In conclusion, the present data seem to suggest that progestin and/or glucocorticoid signals are not only involved in the control of myelin compartment but also on the axon maintenance.
Asunto(s)
Antagonistas de Hormonas/farmacología , Mifepristona/farmacología , Proteína P0 de la Mielina/biosíntesis , Proteína P0 de la Mielina/efectos de los fármacos , Nervio Ciático/efectos de los fármacos , Animales , Axones/efectos de los fármacos , Axones/ultraestructura , Northern Blotting , Western Blotting , Masculino , Microscopía Electrónica , Proteína P0 de la Mielina/ultraestructura , Vaina de Mielina/efectos de los fármacos , Vaina de Mielina/ultraestructura , Proteínas de Neurofilamentos/efectos de los fármacos , Proteínas de Neurofilamentos/ultraestructura , ARN Mensajero/análisis , Ratas , Ratas Sprague-Dawley , Nervio Ciático/ultraestructuraRESUMEN
The myelin and lymphocyte protein (MAL) proteolipid is localized in central and peripheral compact myelin membranes, as well as in apical membranes of particular polarized cells. In this study, we addressed the question whether MAL and other peripheral myelin proteins are sorted and targeted to myelin membranes using mechanisms similar to those observed in polarized epithelial cells. To investigate the presence of raft-mediated sorting pathways in Schwann cells, we have isolated and analysed their composition in myelin membranes. Here, we show that rafts are present in adult human and rat peripheral compact myelin membranes and contain MAL, the GPI-anchored protein CD59, and substantial amounts of the PMP22 and P0. Colocalization studies show that CD59, and MAL have an almost identical expression pattern within compact myelin. Moreover, immuno-electron microscopy revealed that MAL, besides its localization in compact myelin, is also localized to Schmidt-Lanterman incisures. Taken together, our results demonstrate the presence of detergent-insoluble glycolipid-enriched complexes (DIGs) in different compartments of myelin membranes and indicate an important role for DIG-mediated transport mechanisms in the maintenance of the adult myelin sheath.
Asunto(s)
Antígenos CD59/análisis , Microdominios de Membrana/química , Proteínas de Transporte de Membrana , Proteínas de la Mielina/análisis , Vaina de Mielina/química , Nervios Periféricos/química , Proteolípidos/análisis , Anciano , Anciano de 80 o más Años , Animales , Biomarcadores/análisis , Antígenos CD59/biosíntesis , Compartimento Celular , Detergentes/química , Humanos , Sustancias Macromoleculares , Microdominios de Membrana/metabolismo , Microscopía Inmunoelectrónica , Persona de Mediana Edad , Proteína P0 de la Mielina/análisis , Proteína P0 de la Mielina/biosíntesis , Proteínas de la Mielina/biosíntesis , Vaina de Mielina/metabolismo , Vaina de Mielina/ultraestructura , Proteínas Proteolipídicas Asociadas a Mielina y Linfocito , Nervios Periféricos/metabolismo , Nervios Periféricos/ultraestructura , Proteolípidos/biosíntesis , Proteolípidos/ultraestructura , Ratas , Solubilidad , Raíces Nerviosas Espinales/metabolismo , Raíces Nerviosas Espinales/ultraestructuraRESUMEN
We describe a family carrying the Thr148Met mutation in the P0 gene. Contrary to other neuropathies caused by myelin gene defects, no demyeliantion could be found in our biopsies. Based on follow up examinations, extensive morphometry and immunohistochemical analysis we suggest that the mild hypomyelination documented in our family secondarily causes axonal degeneration and axonal loss of large and small fibers which predominates the clinical picture.
Asunto(s)
Axones/patología , Axones/fisiología , Enfermedad de Charcot-Marie-Tooth/diagnóstico , Enfermedad de Charcot-Marie-Tooth/fisiopatología , Proteína P0 de la Mielina/genética , Adulto , Sustitución de Aminoácidos , Biopsia , Recuento de Células , Enfermedad de Charcot-Marie-Tooth/patología , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Mutación , Proteína P0 de la Mielina/biosíntesis , Vaina de Mielina/patología , Glicoproteína Asociada a Mielina/biosíntesis , Conducción Nerviosa , Nervio Sural/metabolismo , Nervio Sural/patología , Nervio Sural/ultraestructuraRESUMEN
The myelin protein P(0) has a major structural role in Schwann cell myelin, and the expression of P(0) protein and mRNA in the Schwann cell lineage has been extensively documented. We show here, using in situ hybridization, that the P(0) gene is also activated in a number of other tissues during embryonic development. P(0) mRNA is first detectable in 10-day-old embryos (E10) and is at this time seen only in cells in the cephalic neural crest and in the otic placode/pit. P(0) expression continues in the otic vesicle and at E12 P(0) expression in this structure largely overlaps with expression of another myelin gene, proteolipid protein. In the developing ear at E14, P(0) expression is complementary to expression of serrate and c-ret mRNAs, which later are expressed in sensory areas of the inner ear, while expression of bone morphogenetic protein (BMP)-4 and P(0), though largely complementary, shows small areas of overlap. P(0) mRNA and protein are detectable in the notochord from E10 to at least E13. In addition to P(0) expression in a subpopulation of trunk crest cells at E11/E12 and in Schwann cell precursors thereafter, P(0) mRNA is also present transiently in a subpopulation of cells migrating in the enteric neural crest pathway, but is down-regulated in these cells at E14 and thereafter. P(0) is also detected in the placode-derived olfactory ensheathing cells from E13 and is maintained in the adult. No signal is seen in cells in the melanocyte migration pathway or in TUJ1 positive neuronal cells in tissue sections. The activation of the P(0) gene in specific tissues outside the nervous system was unexpected. It remains to be determined whether this is functionally significant, or whether it is an evolutionary relic, perhaps reflecting ancestral use of P(0) as an adhesion molecule.
Asunto(s)
Proteínas de Drosophila , Oído Interno/metabolismo , Sistema Nervioso Entérico/metabolismo , Proteína P0 de la Mielina/biosíntesis , Notocorda/metabolismo , Vías Olfatorias/metabolismo , Animales , Adhesión Celular , Linaje de la Célula , Movimiento Celular , ADN Complementario/metabolismo , Regulación hacia Abajo , Oído Interno/embriología , Sistema Nervioso Entérico/embriología , Inmunohistoquímica , Hibridación in Situ , Sistema Nervioso/embriología , Cresta Neural/citología , Cresta Neural/metabolismo , Neuroglía/citología , Neuroglía/metabolismo , Notocorda/embriología , Vías Olfatorias/embriología , Proteínas Proto-Oncogénicas/metabolismo , Proteínas Proto-Oncogénicas c-ret , ARN Mensajero/metabolismo , Ratas , Proteínas Tirosina Quinasas Receptoras/metabolismo , Receptor ErbB-3/biosíntesis , Células de Schwann/metabolismo , Transducción de Señal , Estómago/inervación , Factores de TiempoRESUMEN
Neurofibromas are benign tumors arising from the peripheral nerve sheath and are a typical finding in neurofibromatosis type 1 (NF1). Schwann cells are the predominant cell type in neurofibromas and thus are supposed to play a major role in the pathogenesis of these tumors. It is not known, however, if NF1 mutations in Schwann cells result in an altered phenotype that subsequently leads to tumor formation. To characterize the biological properties of neurofibroma-derived Schwann cells we developed cell culture techniques that enabled us to isolate Schwann cells from neurofibromas and grow them in vitro for several weeks without significant fibroblast contamination. Neurofibroma-derived Schwann cells were characterized by altered morphology, heterogeneous growth behavior, and increased expression of the P0 antigen while several other features of normal human Schwann cells were retained. We conclude that neurofibroma-derived Schwann cells exhibit a distinct phenotype in vitro but that the observed abnormalities by themselves are insufficient to explain neurofibroma formation. Application of our improved culture conditions makes neurofibroma-derived Schwann cells readily available for further studies to define their role in tumorigenesis in neurofibromatosis type 1.